[On the problem of patients with chronic tuberculosis in Prague]. 1967

M Herold, and J Jenicková, and J Tousek, and J Zatecká, and E Matusková

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003604 Czechoslovakia Created as a republic in 1918 by Czechs and Slovaks from territories formerly part of the Austro-Hungarian Empire. The country split into the Czech Republic and Slovakia 1 January 1993.
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

M Herold, and J Jenicková, and J Tousek, and J Zatecká, and E Matusková
May 1973, Praxis der Pneumologie,
M Herold, and J Jenicková, and J Tousek, and J Zatecká, and E Matusková
January 1995, Pneumonologia i alergologia polska,
M Herold, and J Jenicková, and J Tousek, and J Zatecká, and E Matusková
June 1954, Wiener medizinische Wochenschrift (1946),
M Herold, and J Jenicková, and J Tousek, and J Zatecká, and E Matusková
January 1961, Problemy tuberkuleza,
M Herold, and J Jenicková, and J Tousek, and J Zatecká, and E Matusková
January 1950, Boj proti tuberkulose,
M Herold, and J Jenicková, and J Tousek, and J Zatecká, and E Matusková
December 1956, Gruzlica (Warsaw, Poland : 1926),
M Herold, and J Jenicková, and J Tousek, and J Zatecká, and E Matusková
June 1965, Revista clinica espanola,
M Herold, and J Jenicková, and J Tousek, and J Zatecká, and E Matusková
March 1966, Wiener medizinische Wochenschrift (1946),
M Herold, and J Jenicková, and J Tousek, and J Zatecká, and E Matusková
January 1950, Boj proti tuberkulose,
M Herold, and J Jenicková, and J Tousek, and J Zatecká, and E Matusková
November 1957, Ceskoslovenska epidemiologie, mikrobiologie, imunologie,
Copied contents to your clipboard!